These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 30151468)

  • 1. Paget's Disease Mimicking Bone Metastasis in a Patient with Neuroendocrine Tumor on
    Gezer NS; Balcı A; Özdoğan Ö; Özaksoy D
    J Belg Soc Radiol; 2016 Jul; 100(1):66. PubMed ID: 30151468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.
    Wild D; Bomanji JB; Benkert P; Maecke H; Ell PJ; Reubi JC; Caplin ME
    J Nucl Med; 2013 Mar; 54(3):364-72. PubMed ID: 23297077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ga-68 DOTANOC PET/CT imaging in detection of primary site in patients with metastatic neuroendocrine tumours of unknown origin and its impact on clinical decision making: experience from a tertiary care centre in India.
    Pruthi A; Pankaj P; Verma R; Jain A; Belho ES; Mahajan H
    J Gastrointest Oncol; 2016 Jun; 7(3):449-61. PubMed ID: 27284479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 68Ga-DOTATOC versus 68Ga-DOTATATE PET/CT in functional imaging of neuroendocrine tumors.
    Poeppel TD; Binse I; Petersenn S; Lahner H; Schott M; Antoch G; Brandau W; Bockisch A; Boy C
    J Nucl Med; 2011 Dec; 52(12):1864-70. PubMed ID: 22072704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential uptake of (68)Ga-DOTATOC and (68)Ga-DOTATATE in PET/CT of gastroenteropancreatic neuroendocrine tumors.
    Poeppel TD; Binse I; Petersenn S; Lahner H; Schott M; Antoch G; Brandau W; Bockisch A; Boy C
    Recent Results Cancer Res; 2013; 194():353-71. PubMed ID: 22918768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin receptor expression in lymphomas: a source of false diagnosis of neuroendocrine tumor at
    Ruuska T; Ramírez Escalante Y; Vaittinen S; Gardberg M; Kiviniemi A; Marjamäki P; Kemppainen J; Jyrkkiö S; Minn H
    Acta Oncol; 2018 Feb; 57(2):283-289. PubMed ID: 28686510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased [
    Firsova M; Treglia G; Sempoux C; Dromain C; Prior JO; Schaefer N; Boughdad S
    EJNMMI Rep; 2024 Jun; 8(1):18. PubMed ID: 38910232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity Comparison of
    Nicolas GP; Schreiter N; Kaul F; Uiters J; Bouterfa H; Kaufmann J; Erlanger TE; Cathomas R; Christ E; Fani M; Wild D
    J Nucl Med; 2018 Jun; 59(6):915-921. PubMed ID: 29191855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of radioactive substances in diagnosis and treatment of neuroendocrine tumors.
    Kjaer A; Knigge U
    Scand J Gastroenterol; 2015 Jun; 50(6):740-7. PubMed ID: 25959100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic role of Gallium-68 DOTATOC and Gallium-68 DOTATATE PET in patients with neuroendocrine tumors: a meta-analysis.
    Yang J; Kan Y; Ge BH; Yuan L; Li C; Zhao W
    Acta Radiol; 2014 May; 55(4):389-98. PubMed ID: 23928010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective Multicentric Assessment of
    Lugat A; Frampas É; Touchefeu Y; Mirallié É; Bras ML; Senellart H; Rauscher A; Fleury V; Campion L; Rohmer V; Couturier OF; Lebtahi R; Rouzet F; Ruszniewski P; Kraeber-Bodéré F; Bourgeois M; Ansquer C
    Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Head-to-Head Comparison of SSTR Antagonist [
    Viswanathan R; Ballal S; Yadav MP; Roesch F; Sheokand P; Satapathy S; Tripathi M; Agarwal S; Moon ES; Bal C
    Pharmaceuticals (Basel); 2024 Feb; 17(3):. PubMed ID: 38543061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration of focal physiologic in-vivo somatostatin receptor expression in the caput epididymis of the testes on
    Parihar AS; Sood A; Sood A; Gulati A; Mittal BR
    Asia Ocean J Nucl Med Biol; 2020; 8(2):132-135. PubMed ID: 32715001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-Body 68Ga-DOTANOC PET/MRI Versus 68Ga-DOTANOC PET/CT in Patients With Neuroendocrine Tumors: A Prospective Study in 28 Patients.
    Berzaczy D; Giraudo C; Haug AR; Raderer M; Senn D; Karanikas G; Weber M; Mayerhoefer ME
    Clin Nucl Med; 2017 Sep; 42(9):669-674. PubMed ID: 28682844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative and qualitative intrapatient comparison of 68Ga-DOTATOC and 68Ga-DOTATATE: net uptake rate for accurate quantification.
    Velikyan I; Sundin A; Sörensen J; Lubberink M; Sandström M; Garske-Román U; Lundqvist H; Granberg D; Eriksson B
    J Nucl Med; 2014 Feb; 55(2):204-10. PubMed ID: 24379222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 68Ga-DOTANOC PET/CT clinical impact in patients with neuroendocrine tumors.
    Ambrosini V; Campana D; Bodei L; Nanni C; Castellucci P; Allegri V; Montini GC; Tomassetti P; Paganelli G; Fanti S
    J Nucl Med; 2010 May; 51(5):669-73. PubMed ID: 20395323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with
    Sampathirao N; Basu S
    J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-to-Blood Ratio for Assessment of Somatostatin Receptor Density in Neuroendocrine Tumors Using
    Ilan E; Velikyan I; Sandström M; Sundin A; Lubberink M
    J Nucl Med; 2020 Feb; 61(2):217-221. PubMed ID: 31302632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An orthotopic model of pancreatic somatostatin receptor (SSTR)-positive tumors allows bimodal imaging studies using 3T MRI and animal PET-based molecular imaging of SSTR expression.
    Stelter L; Amthauer H; Rexin A; Pinkernelle J; Schulz P; Michel R; Denecke T; Stiepani H; Hamm B; Wiedenmann B; Scholz A
    Neuroendocrinology; 2008; 87(4):233-42. PubMed ID: 18025811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.